GOSSAMER BIO, INC. (GOSS) /

The cash flow of GOSSAMER BIO, INC. over the past 9 years

Chart GOSSAMER BIO, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2017–2025 Open the chart →

In fiscal 2025, the latest fiscal year on file, GOSSAMER BIO, INC.'s operating cash flow was -$171.27M and its capital expenditures $79K, leaving free cash flow of -$171.34M. Free cash flow was below zero in all 8 years shown. It ranged from -$190.44M in fiscal 2021 to -$3.47M in fiscal 2024. Capital expenditures were highest in fiscal 2018, at $3.49M.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2025ended Dec 31, 2025-$171.27M$79K-$171.34M
2024ended Dec 31, 2024-$3.47M$0-$3.47M
2023ended Dec 31, 2023-$159.16M$0-$159.16M
2022ended Dec 31, 2022-$187.03M$410K-$187.44M
2021ended Dec 31, 2021-$188.89M$1.55M-$190.44M
2020ended Dec 31, 2020-$176.36M$1.5M-$177.86M
2019ended Dec 31, 2019-$144.83M$2.97M-$147.8M
2018ended Dec 31, 2018-$51.04M$3.49M-$54.53M
2017ended Dec 31, 2017———

Fiscal years as GOSSAMER BIO, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on GOSSAMER BIO, INC.

Companies of a similar size

Not investment advice. This page shows what GOSSAMER BIO, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.